News Listing

Filter by
Date
MEDIA RELEASE: Jun 15, 2017 04:00 AM

Breakthrough in reptile temperature sex-swap research

Researchers from the University of Canberra, Garvan, La Trobe University and CSIRO may have solved the 50-year mystery of how temperature affects sex determination in reptiles. The team studied Australia's bearded dragon...

Jun 13, 2017 01:00 AM

“We’re seeing things we’ve never seen before”: peering deepe...

University of Copenhagen researchers – including Dr Thomas Cox, who now leads a group in Garvan’s Cancer Division – have developed an intuitive new way to dissolve cells away from tissues and tumours. The new approach ma...

Jun 12, 2017 11:10 AM

Queen’s Birthday Honour for Professor John Shine

Garvan warmly congratulates Professor John Shine AO FAA, who has today been made a Companion of the Order of Australia (AC).

Jun 07, 2017 04:21 PM

International data visualisation experts converge on Sydney ...

Garvan, CSIRO, and The University of Sydney have proudly joined forces to deliver the VIZBI series of events, held as part of Vivid Sydney during June 2017.

MEDIA RELEASE: Jun 07, 2017 12:30 AM

Genome.One news: World-leading Australian intelligent data c...

Sydney-based health information company Genome.One®, backed by the Garvan Institute of Medical Research, has secured a new partnership for its pioneering health information technology with one of the biggest health syste...

MEDIA RELEASE: Jun 05, 2017 04:20 PM

When worlds collide: bridging science with art, design and a...

'VizbiPlus: Bridging science with art, design and animation' is an entertaining and stimulating soiree to be held at the Vivid Ideas Exchange at the Museum of Contemporary Art in Sydney, from 5pm-7pm on Monday 12 June 20...

MEDIA RELEASE: May 16, 2017 10:42 PM

Tumour-trained T cells go on patrol

‘Tumour-trained’ immune cells – which have the potential to kill cancer cells – have been seen moving from one tumour to another for the first time. The new findings, which were uncovered by scientists at Sydney’s Garvan...

May 12, 2017 08:00 AM

PKD Australia funding to help develop diagnostic tool for ki...

Garvan researcher Dr Amali Mallawaarachchi has been awarded a grant from the Polycystic Kidney Disease Foundation of Australia to support the development of an improved genomic diagnostic tool for individuals with kidney...

May 11, 2017 02:52 PM

Love Your Sister's Big Heart Project raises over $2 million ...

History was made in Canberra yesterday, when the Big Heart Project, an initiative of Love Your Sister, raised a remarkable $2.2 million for cancer research at Garvan.

MEDIA RELEASE: May 11, 2017 12:05 AM

Proteins on the loose in a debilitating childhood disease

Australian scientists have shown, for the first time, that a family of untethered proteins builds up in the cells of children with a rare and serious genetic condition, known as mevalonate kinase deficiency (MKD).

May 09, 2017 06:00 AM

Annual awards celebrate key Garvan researchers

Garvan congratulates Dr Thomas Cox, Dr Simon Junankar, Dr Romain Rouet and Dr Sean Warren, winners of the annual Ridley Ken Davies Award, CHAMP Young Pioneer Award and the Palmer Innovation Prize.

MEDIA RELEASE: May 08, 2017 06:00 AM

TRACEBACK for change in ovarian cancer

Australian women diagnosed with ovarian cancer before 2013, and their families, will be proactively identified and offered genetic testing for the BRCA1 and BRCA2 genes through a new international study, ‘TRACEBACK’.

May 06, 2017 11:14 AM

From basic research to the clinic: reflections on a key immu...

Last week (April 24-28), immunologists from round the world converged on Whistler (BC, Canada) for a Keystone Meeting on B Cells and T Follicular Helper Cells – the cells in our immune system that are crucial for long-te...

May 04, 2017 04:07 PM

Professor Jonathan Sprent elected to US National Academy of ...

Garvan congratulates Professor Jonathan Sprent, of the Institute’s Immunology Division, who has been newly elected as a member of the US National Academy of Sciences (NAS). Membership of the NAS is considered one of the ...

Apr 13, 2017 07:03 PM

John Mattick: Whole genome sequencing is medicine’s Snowy Sc...

In this opinion piece in The Australian, Garvan's Executive Director, Professor John Mattick AO FAA says that Australia could be a front runner in precision medicine – but we need to act now.

MEDIA RELEASE: Apr 11, 2017 03:32 PM

Science and art collaborate on visualising biological data d...

Garvan, CSIRO’s Data61, and the Charles Perkins Centre at The University of Sydney are joining forces for a series of events held as part of Vivid Sydney, showcasing visualisations that are transforming how life scientis...

MEDIA RELEASE: Apr 11, 2017 12:53 PM

Mapping the genome of prostate cancer uncovers a new world o...

Researchers have ‘mapped’ the entire genome of a prostate tumour, revealing previously undetected levels of DNA rearrangements. The findings, from the Garvan Institute of Medical Research, provide an entirely new lens th...

MEDIA RELEASE: Apr 11, 2017 07:22 AM

Garvan Institute marks 200th anniversary of Parkinson’s dise...

Today, World Parkinson’s Day marks 200 years since the disease was first identified by Dr James Parkinson.

MEDIA RELEASE: Apr 11, 2017 05:45 AM

World Parkinson's Day: “Fish with Parkinson’s” uncover a dr...

Australian scientists have developed a first-of-its-kind model of Parkinson’s disease in zebrafish. In the model, neurodegeneration occurs through a combination of genetic and environmental factors – just as it does in p...

Apr 10, 2017 11:47 AM

Garvan and Asan Medical Center sign agreement to advance gen...

The Garvan Institute of Medical Research and the Asan Medical Center Cancer Institute in Seoul, South Korea, have signed a Memorandum of Understanding (MOU), formalising a cooperative relationship between the two institu...

MEDIA RELEASE: Apr 07, 2017 02:00 AM

“The best tool of its kind in the world”: Patient Archive be...

Western Australia’s Undiagnosed Diseases Program (UDP) has acquired Patient Archive clinical phenotyping software from the Garvan Institute of Medical Research.